Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
NCT01916122
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Fluorestradiol (FES)
PROCEDURE:
PET/CT Imaging
Sponsor
Memorial Sloan Kettering Cancer Center